Advertisement

Pediatric Drugs

, Volume 1, Issue 1, pp 3–5 | Cite as

Why Do We Need a New Journal in Paediatric Pharmacology?

  • Gilman D. Grave
  • George P. Giacoia
  • Sumner J. Yaffe
Leading Article

Keywords

Adis International Limited Molecular Entity Paediatric Drug Paediatr Drug Pediatric Clinical Pharmacology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Parker SG. Finding the 3% of journal articles worth reading. Intern Med News 1998; 31: 38Google Scholar
  2. 2.
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA 1998; 279: 1200–5PubMedCrossRefGoogle Scholar
  3. 3.
    Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients: final rule. Fed Regist 1998; 63: 66632–72Google Scholar
  4. 4.
    Kauffman R. Oral testimony for the American Academy of Pediatrics. US House Commerce Committee; 1998 Oct 7Google Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Gilman D. Grave
    • 1
  • George P. Giacoia
    • 2
  • Sumner J. Yaffe
    • 3
  1. 1.Endocrinology, Nutrition and Growth Branch, Center for Research for Mothers and ChildrenNational Institute of Child Health and Human DevelopmentBethesdaUSA
  2. 2.Pediatric Pharmacology Research Unit Network, Endocrinology, Nutrition and Growth Branch, Center for Research for Mothers and ChildrenNational Institute of Child Health and Human DevelopmentBethesdaUSA
  3. 3.Center for Research for Mothers and ChildrenNational Institute of Child Health and Human Development, Executive Building Room 4B05BethesdaUSA

Personalised recommendations